DrugUse-v3.4.1(2023EN): verschil tussen versies

Uit Zorginformatiebouwstenen
Naar navigatie springen Naar zoeken springen
(Nieuwe pagina aangemaakt met '<!-- Hieronder wordt een transclude page aangeroepen --> {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(EN)|1|DrugUse-v3.4.1(2023EN)}} <!-- Tot hier de transclude page --> ==General information<!--hdGeneralInformation-->== Name<!--hdName-->: '''nl.zorg.DrugUse''' link=DrugsGebruik-v3.4.1(2023NL)<BR> Version<!--hdVersion-->: '''3.4.1''' <br> HCIM Status<!--hdStatus-->:Final<br> Release<!--hdPublication-->: '''2023''' <br> Release s...')
 
Geen bewerkingssamenvatting
 
Regel 26: Regel 26:
|style="width:250px; "|DCM::ContactInformation.Telecom||*
|style="width:250px; "|DCM::ContactInformation.Telecom||*
|-  
|-  
|style="width:250px; "|DCM::ContentAuthorList||Projectgroep Generieke Overdrachtsgegevens &amp; Kerngroep Registratie aan de Bron
|style="width:250px; "|DCM::ContentAuthorList||Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
|-  
|-  
|style="width:250px; "|DCM::CreationDate||5-7-2012
|style="width:250px; "|DCM::CreationDate||5-7-2012
Regel 54: Regel 54:
|style="width:250px; "|DCM::PublicationStatus||Prepublished
|style="width:250px; "|DCM::PublicationStatus||Prepublished
|-  
|-  
|style="width:250px; "|DCM::ReviewerList||Projectgroep Generieke Overdrachtsgegevens &amp; Kerngroep Registratie aan de Bron
|style="width:250px; "|DCM::ReviewerList||Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
|-  
|-  
|style="width:250px; "|DCM::RevisionDate||08-09-2023
|style="width:250px; "|DCM::RevisionDate||08-09-2023
Regel 101: Regel 101:
|-
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-312 | ZIB-312 ]]
|style="width:75px; "|[[ZIBIssues500_0#ZIB-312 | ZIB-312 ]]
|aanpassing paragraaf &#39;Concept&#39;
|aanpassing paragraaf 'Concept'
|-
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-313 | ZIB-313 ]]
|style="width:75px; "|[[ZIBIssues500_0#ZIB-313 | ZIB-313 ]]
|Aanpassen paragraaf &#39;Purpose&#39;
|Aanpassen paragraaf 'Purpose'
|-
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-316 | ZIB-316 ]]
|style="width:75px; "|[[ZIBIssues500_0#ZIB-316 | ZIB-316 ]]
|Paragraaf &#39;Evidence base&#39; wijzigen
|Paragraaf 'Evidence base' wijzigen
|-
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-319 | ZIB-319 ]]
|style="width:75px; "|[[ZIBIssues500_0#ZIB-319 | ZIB-319 ]]
Regel 117: Regel 117:
|-
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-94 | ZIB-94 ]]
|style="width:75px; "|[[ZIBIssues500_0#ZIB-94 | ZIB-94 ]]
|Aanpassen tekst van Disclaimer, Terms of Use &amp; Copyrights
|Aanpassen tekst van Disclaimer, Terms of Use & Copyrights
|-
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-154 | ZIB-154 ]]
|style="width:75px; "|[[ZIBIssues500_0#ZIB-154 | ZIB-154 ]]
Regel 142: Regel 142:
|-
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-388 | ZIB-388 ]]
|style="width:75px; "|[[ZIBIssues500_0#ZIB-388 | ZIB-388 ]]
|De ToedieningswegCodelijst heeft geen &quot;OID: &quot; aanduiding in de onderliggende codelijst.
|De ToedieningswegCodelijst heeft geen "OID: " aanduiding in de onderliggende codelijst.
|}
|}


Regel 156: Regel 156:
|-
|-
|style="width:75px; "|[[ZIBIssues500_0#ZIB-453 | ZIB-453 ]]
|style="width:75px; "|[[ZIBIssues500_0#ZIB-453 | ZIB-453 ]]
|Wijziging naamgeving ZIB&#39;s en logo&#39;s door andere opzet van beheer
|Wijziging naamgeving ZIB's en logo's door andere opzet van beheer
|}
|}


Regel 505: Regel 505:
|Description<!--vsDescription-->
|Description<!--vsDescription-->
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|<span title = "Hero&#239;ne (substance)">Diamorphine</span>
|<span title = "Heroïne (substance)">Diamorphine</span>
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387341002 387341002]
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387341002 387341002]
|SNOMED CT
|SNOMED CT
|2.16.840.1.113883.6.96
|2.16.840.1.113883.6.96
|Hero&#239;ne
|Heroïne
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|<span title = "Benzodiazepine (substance)">Benzodiazepine</span>
|<span title = "Benzodiazepine (substance)">Benzodiazepine</span>
Regel 529: Regel 529:
|GHB
|GHB
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|<span title = "Coca&#239;ne (substance)">Cocaine</span>
|<span title = "Cocaïne (substance)">Cocaine</span>
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387085005 387085005]
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387085005 387085005]
|SNOMED CT
|SNOMED CT
|2.16.840.1.113883.6.96
|2.16.840.1.113883.6.96
|Coca&#239;ne
|Cocaïne
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|<span title = "Crack (substance)">Cocaine freebase</span>
|<span title = "Crack (substance)">Cocaine freebase</span>
Regel 563: Regel 563:
|SNOMED CT
|SNOMED CT
|2.16.840.1.113883.6.96
|2.16.840.1.113883.6.96
|Paddo&#39;s
|Paddo's
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|<span title = "LSD (substance)">Lysergic acid diethylamide</span>
|<span title = "LSD (substance)">Lysergic acid diethylamide</span>
Regel 589: Regel 589:
|Crystal meth, methamfetamine
|Crystal meth, methamfetamine
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|<span title = "Anabool stero&#239;d (substance)">Anabolic androgenic steroid</span>
|<span title = "Anabool steroïd (substance)">Anabolic androgenic steroid</span>
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=111151007 111151007]
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=111151007 111151007]
|SNOMED CT
|SNOMED CT
|2.16.840.1.113883.6.96
|2.16.840.1.113883.6.96
|Anabole stero&#239;de
|Anabole steroïde
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|<span title = "Laxans (substance)">Laxative</span>
|<span title = "Laxans (substance)">Laxative</span>
Regel 619: Regel 619:
|Barbituraat
|Barbituraat
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|<span title = "Opio&#239;dreceptoragonist (substance)">Opioid receptor agonist</span>
|<span title = "Opioïdreceptoragonist (substance)">Opioid receptor agonist</span>
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=404642006 404642006]
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=404642006 404642006]
|SNOMED CT
|SNOMED CT
|2.16.840.1.113883.6.96
|2.16.840.1.113883.6.96
|Opiaten zoals morfine, code&#239;ne, methadon, oxycodon en andere morfine-derivaten
|Opiaten zoals morfine, codeïne, methadon, oxycodon en andere morfine-derivaten
|-style="vertical-align:top; "
|-style="vertical-align:top; "
|<span title = "4-fluoramfetamine (substance)">4-Fluoroamphetamine</span>
|<span title = "4-fluoramfetamine (substance)">4-Fluoroamphetamine</span>
Regel 660: Regel 660:
:--
:--
==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->==
==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->==
To exchange information based on health and care information models, additional, more technical specifications are required.&lt;BR&gt;
To exchange information based on health and care information models, additional, more technical specifications are required.<BR>
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:<!--ftReferenceIntro-->
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:<!--ftReferenceIntro-->
<ul>
<ul>
<li>HL7&#174; version 3 CDA compatible specifications, available through the Nictiz ART-DECOR&#174; environment<!--ftArtDecorReference--> {{ArtDecorLinks|2023|7.4}}</li>
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment<!--ftArtDecorReference--> {{ArtDecorLinks|2023|7.4}}</li>
<li>HL7&#174; FHIR&#174; compatible specifications, available through the Nictiz environment on the Simplifier FHIR<!--ftSimplifierReference--> {{SimplefierLinks|2023|DrugsGebruik}}</li>
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR<!--ftSimplifierReference--> {{SimplefierLinks|2023|DrugsGebruik}}</li>
</ul>
</ul>
==Downloads<!--ftDownloadTitle-->==
==Downloads<!--ftDownloadTitle-->==
Regel 676: Regel 676:
</ul>
</ul>
Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>
Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>
This page is generated on 26/10/2023 15:50:18 with ZibExtraction v. 9.0.8682.20490<!--ftDate--> <BR>
This page is generated on 31/10/2023 18:33:57 with ZibExtraction v. 9.3.8704.31782<!--ftDate--> <BR>
-----
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2023(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2023(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2023(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2023(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>

Huidige versie van 31 okt 2023 om 19:59


Attention!! This is not the most recent version of this information model. You can find the most recent version ''here''.

General information

Name: nl.zorg.DrugUse NL.png
Version: 3.4.1
HCIM Status:Final
Release: 2023
Release status: Prepublished
Release date: 15-10-2023

Back 16.png Back to HCIM list

Metadata

DCM::CoderList Kerngroep Registratie aan de Bron
DCM::ContactInformation.Address *
DCM::ContactInformation.Name *
DCM::ContactInformation.Telecom *
DCM::ContentAuthorList Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
DCM::CreationDate 5-7-2012
DCM::DeprecatedDate
DCM::DescriptionLanguage nl
DCM::EndorsingAuthority.Address
DCM::EndorsingAuthority.Name PM
DCM::EndorsingAuthority.Telecom
DCM::Id 2.16.840.1.113883.2.4.3.11.60.40.3.7.4
DCM::KeywordList drugsgebruik, verdovende middelen, middelen gebruik, drugs
DCM::LifecycleStatus Final
DCM::ModelerList Kerngroep Registratie aan de Bron
DCM::Name nl.zorg.DrugsGebruik
DCM::PublicationDate 15-10-2023
DCM::PublicationStatus Prepublished
DCM::ReviewerList Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
DCM::RevisionDate 08-09-2023
DCM::Supersedes nl.zorg.DrugsGebruik-v3.4
DCM::Version 3.4.1
HCIM::PublicationLanguage EN

Revision History

Only available in Dutch

Publicatieversie 1.0 (15-02-2013)

Publicatieversie 1.1 (01-07-2013)

Publicatieversie 1.2 (01-04-2015)

ZIB-138 Aanpassingen in SNOMED CT codes en omschrijvingen voor codelijst DrugsGebruikStatusCodelijst n.a.v. review terminologie expert.
ZIB-139 Aanpassingen in SNOMED CT codes en omschrijvingen voor codelijst DrugsOfGeneesmiddelSoortCodelijst n.a.v. review terminologie expert.
ZIB-158 Cardinaliteit SoortMiddel aanpassen in bouwsteen OverdrachtDrugsgebruik
ZIB-161 Het concept Hoeveelheid van bouwsteen OverdrachtDrugsgebruik.
ZIB-167 Bevindingen Concept inrichting Intoxicatie Roken/ Alcohol en Drugs in EZIS.NET
ZIB-224 In de klinische bouwsteen OverdrachtDrugsgebruik, concept SoortMiddel komt tagged value DrugsOfGeneesmiddelSoortCodelijst niet overeen met naam gekoppelde valueset DrugsOfGeneesmiddelSoort.
ZIB-225 In de klinische bouwsteen OverdrachtDrugsgebruik, concept ToedieningsWeg komt tagged value ToedieningsWegCodelijst niet overeen met naam gekoppelde valueset.
ZIB-308 Prefix Overdracht weggehaald bij de generieke bouwstenen
ZIB-312 aanpassing paragraaf 'Concept'
ZIB-313 Aanpassen paragraaf 'Purpose'
ZIB-316 Paragraaf 'Evidence base' wijzigen
ZIB-319 Wijzing paragraaf Constraint

Incl. algemene wijzigingsverzoeken:

ZIB-94 Aanpassen tekst van Disclaimer, Terms of Use & Copyrights
ZIB-154 Consequenties opsplitsing Medicatie bouwstenen voor overige bouwstenen.
ZIB-200 Naamgeving SNOMED CT in tagged values klinische bouwstenen gelijk getrokken.
ZIB-201 Naamgeving OID: in tagged value notes van klinische bouwstenen gelijk getrokken.
ZIB-309 EOI aangepast
ZIB-324 Codelijsten Name en Description beginnen met een Hoofdletter
ZIB-326 Tekstuele aanpassingen conform de kwaliteitsreview kerngroep 2015

Publicatieversie 1.2.1 (22-05-2015)

ZIB-388 De ToedieningswegCodelijst heeft geen "OID: " aanduiding in de onderliggende codelijst.

Publicatieversie 1.2.2 (16-07-2015)

ZIB-418 Vervallen SNOMED CT code in DrugsOfGeneesmiddelSoortCodelijst

Publicatieversie 3.0 (01-05-2016)

ZIB-453 Wijziging naamgeving ZIB's en logo's door andere opzet van beheer

Publicatieversie 3.1 (04-09-2017)

ZIB-475 Terminologiekoppeling Drugsgebruik
ZIB-488 niet compleet
ZIB-505 Geen informatie
ZIB-512 Hoe houd je verschillende adresgegevens uit elkaar?
ZIB-564 Aanpassing/harmonisatie Engelse conceptnamen

Publicatieversie 3.2 (31-12-2017)

ZIB-555 Uitbreiding codelijst van ZIB DrugsGebruik

Publicatieversie 3.3 (01-09-2020)

ZIB-936 DrugsGebruikStatusCodelijst vertalingen corrigeren
ZIB-1181 DefinitionCodes zib drugGebruik

Publicatieversie 3.4 (01-12-2021)

ZIB-1009 Aanvullingen zib druggebruik: waardenlijst middelen
ZIB-1302 Uitbreiding DrugsOfGeneesmiddelSoortCodelijst van de zib DrugsGebruik
ZIB-1575 Deprecated termen en waardelijsten uit de prepublicatie halen

Publicatieversie 3.4.1 (15-10-2023)

ZIB-1974 Suggested typo and textual improvements

Concept

Drugs (or: narcotics, amphetamines, intoxicants, highs, hallucinogenics, illegal substances or dope) is a collective term for drugs and chemical substances with a more or less ‘drugging' (anesthetic, boosting and/or hallucinogenic) effect and which can lead to addiction. Drug [Online] Available at: nl.Wikipedia.org/wiki/drug [Accessed: 11 February 2015].

This information model describes the information asked of the patient about their drug use.

Purpose

Documenting and sharing registration of the drug use, as described in the concept.

Evidence Base

Though this information model can also be used to abuse (the patient’s own) medication, the project group eventually decided to focus on information on drug use, as described in the concept.
Seeing as there is a large variety of ways to record the amount of drugs used, we decided that this part is to be entered as free text.

Information Model


#647#RouteOfAdministrationCodelist#DrugUseStatusCodelist#652#645#TypeOfDrugOrMedicationCodelist#646#650#642#649#643#641DrugUse-v3.4.1Model(2023EN).png


Type Id Concept Card. Definition DefinitionCode Reference
Block.png NL-CM:7.4.1 Arrowdown.pngDrugUse Root concept of the DrugUse information model. This concept contains all data elements of the DrugUse information model.
228366006 Finding relating to drug misuse behavior
Folder.png NL-CM:7.4.5 Arrowdown.pngObservationOfUse 0..1 Container for ObservationOfUse. This container contains all data elements of the ObservationOfUse container.
TS.png NL-CM:7.4.6 Arrowright.pngStartDate 0..1 The date on which the patient started using.
TS.png NL-CM:7.4.7 Arrowright.pngStopDate 0..1 The date on which the patient quit using.
ST.png NL-CM:7.4.8 Arrowright.pngAmount 0..1 The number of units (pills, joints, shots etc.) per day, week, month, or year; or the frequency of use.
ST.png NL-CM:7.4.9 Arrowright.pngComment 0..1 Relevant comments on the drug use.
48767-8 Annotation comment [Interpretation] Narrative
CD.png NL-CM:7.4.2 Arrowright.pngDrugOrMedicationType 0..1 Type of drug used by the patient.
List2.png TypeOfDrugOrMedicationCodelist
CD.png NL-CM:7.4.3 Arrowright.pngDrugUseStatus 1 Indication stating whether there was any drug use in the past or present.
228366006 Finding relating to drug misuse behavior
List2.png DrugUseStatusCodelist
CD.png NL-CM:7.4.4 Arrowright.pngRouteOfAdministration 0..* The way the drugs are used.
410675002 Route of administration
List2.png RouteOfAdministrationCodelist

Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page List2.png

Example Instances

Only available in Dutch

DrugsOfGeneesmiddel Drugs Gebruik Status Start datum Stop datum Toedieningsweg Hoeveelheid Toelichting
XTC misbruikt drugs 1985 oraal 2x per maand Op feestjes en in uitgaanscircuit. Vroeger wat meer dan tegenwoordig.
DrugsOfGeneesmiddel Drugs Gebruik Status Start datum Stop datum Toedieningsweg Hoeveelheid Toelichting
Heroïne heeft in het verleden drugs gebruikt 1970 1985 intraveneus 3x per week

Instructions

The 'DrugOrMedicationTypeCodelist is extensible. If the drug in question is not on the codelist, the list can be extended with a code from the SNOMED CT hierarchy 'Substance; <105590001' or if necessary from the hierarchy 'Pharmaceutical/biologic product; < 373873005'.

Valuesets

DrugUseStatusCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2 Binding: Extensible
Conceptname Conceptcode Codesystem name Codesystem OID Description
Current drug user 417284009 SNOMED CT 2.16.840.1.113883.6.96 huidige drugsgebruiker
Does not misuse drugs 228367002 SNOMED CT 2.16.840.1.113883.6.96 gebruikt geen drugs
Has never misused drugs 228368007 SNOMED CT 2.16.840.1.113883.6.96 heeft nooit drugs gebruikt
Misused drugs in past 44870007 SNOMED CT 2.16.840.1.113883.6.96 heeft in het verleden drugs gebruikt
Other OTH NullFlavor 2.16.840.1.113883.5.1008 anders

RouteOfAdministrationCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.3 Binding: Extensible
Conceptname Conceptcode Codesystem name Codesystem OID Description
ORAAL 9 G-Standaard Toedieningswegen 2.16.840.1.113883.2.4.4.9 oraal
NASAAL 6 G-Standaard Toedieningswegen 2.16.840.1.113883.2.4.4.9 nasaal (snuiven)
INHALATIE 62 G-Standaard Toedieningswegen 2.16.840.1.113883.2.4.4.9 Inhalatie (roken)
INTRAVENEUS 5 G-Standaard Toedieningswegen 2.16.840.1.113883.2.4.4.9 Intraveneus (spuiten)
Other OTH NullFlavor 2.16.840.1.113883.5.1008 Anders

TypeOfDrugOrMedicationCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1 Binding: Extensible
Conceptname Conceptcode Codesystem name Codesystem OID Description
Diamorphine 387341002 SNOMED CT 2.16.840.1.113883.6.96 Heroïne
Benzodiazepine 372664007 SNOMED CT 2.16.840.1.113883.6.96 Benzodiazepine
Methadone 387286002 SNOMED CT 2.16.840.1.113883.6.96 Methadon
Hydroxybutyric acid 62821004 SNOMED CT 2.16.840.1.113883.6.96 GHB
Cocaine 387085005 SNOMED CT 2.16.840.1.113883.6.96 Cocaïne
Cocaine freebase 229003004 SNOMED CT 2.16.840.1.113883.6.96 Crack, base coke
Methylenedioxymethamphetamine 288459003 SNOMED CT 2.16.840.1.113883.6.96 MDMA
Amphetamine 703842006 SNOMED CT 2.16.840.1.113883.6.96 Amfetamine, speed
Cannabis 398705004 SNOMED CT 2.16.840.1.113883.6.96 Cannabis, wiet marihuana, hasj
Hallucinogenic mushrooms 229006007 SNOMED CT 2.16.840.1.113883.6.96 Paddo's
Lysergic acid diethylamide 15698006 SNOMED CT 2.16.840.1.113883.6.96 LSD
Ketamine 373464007 SNOMED CT 2.16.840.1.113883.6.96 Ketamine
Phencyclidine 9721008 SNOMED CT 2.16.840.1.113883.6.96 PCP
Methamphetamine 387499002 SNOMED CT 2.16.840.1.113883.6.96 Crystal meth, methamfetamine
Anabolic androgenic steroid 111151007 SNOMED CT 2.16.840.1.113883.6.96 Anabole steroïde
Laxative 372800002 SNOMED CT 2.16.840.1.113883.6.96 Laxans
Buprenorphine 387173000 SNOMED CT 2.16.840.1.113883.6.96 Buprenorfine
Fentanyl 373492002 SNOMED CT 2.16.840.1.113883.6.96 Fentanyl
Barbiturate 372798009 SNOMED CT 2.16.840.1.113883.6.96 Barbituraat
Opioid receptor agonist 404642006 SNOMED CT 2.16.840.1.113883.6.96 Opiaten zoals morfine, codeïne, methadon, oxycodon en andere morfine-derivaten
4-Fluoroamphetamine 33471000146101 SNOMED CT 2.16.840.1.113883.6.96 4FA en/of 4-fmp
Oxycodone 55452001 SNOMED CT 2.16.840.1.113883.6.96 Oxycodon
Nitrous oxide 111132001 SNOMED CT 2.16.840.1.113883.6.96 Lachgas
Other OTH NullFlavor 2.16.840.1.113883.5.1008 Anders

This information model in other releases

Information model references

This information model refers to

--

This information model is used in

--

Technical specifications in HL7v3 CDA and HL7 FHIR

To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:

  • HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment Artdecor.jpg
  • HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR Fhir.png

Downloads

This information model is also available as pdf file PDF.png or as spreadsheet Xlsx.png

About this information

The information in this wikipage is based on Prerelease 2023-1
SNOMED CT and LOINC codes are based on:

  • SNOMED Clinical Terms versie: 20230930 [R] (september 2023-editie)
  • LOINC version 2.76

Conditions for use are located on the mainpage List2.png
This page is generated on 31/10/2023 18:33:57 with ZibExtraction v. 9.3.8704.31782

Back 16.png Back to HCIM list
Overgenomen van "https://zibs.test-nictiz.nl/index.php?title=DrugUse-v3.4.1(2023EN)&oldid=27089"